Upstate Active Clinical Trials

Study Title:

A082002: A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer

What is the purpose of the study? (in Layman's terms, please describe the study)

We are doing this study because we want to find out if this approach is better or worse than the usual approach for your lung cancer. The usual approach is defined as care most people get for advanced stage non-small cell lung cancer.

Upstate Institutional Review Board (IRB) Number:

1921535

Study/Protocol ID:

A082002

Study Phase:

II/III

Patient Age Group:

Adults

Principal Investigator:

Michael D Mix, MD

Who is eligible?

You may be eligible to take part in this study if you have advanced lung cancer. Other inclusion criteria apply. Please contact the CRA for more information.

What is involved if I participate?

• How long is the study?
  5 years
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  Yes
• What tests and procedures are involved?
  Please contact the CRA for more information.

Where will the study take place?

Upstate Cancer Center - all procedures.
Oswego - all procedures.
Oneida - all procedures.
The Hill Radiation Oncology

Other Information:

Please contact the CRA for more information.

Who can I contact for more information?

Name: Erin Bingham, CCRP
Phone: 315-464-3603
Email: [email protected]

Return to Previous Page || Search Again